Analysis of Data on Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy for Chronic Lymphocytic Leukemia Shows High Patient Heterogeneity and the Need for More Consideration of Individualized Treatment
Type
Retraction
Notice date
12/13/2023 0:00
Journal
Computational and Mathematical Methods in Medicine